- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01881295
Bioavailability of Potassium From Potatoes and Potassium Gluconate (Potato)
Study Overview
Status
Conditions
Intervention / Treatment
- Dietary supplement: Placebo control
- Dietary supplement: Low dose potassium gluconate
- Dietary supplement: Medium dose potassium gluconate
- Dietary supplement: High dose potassium gluconate
- Dietary supplement: Low dose potato
- Dietary supplement: Medium dose potato
- Dietary supplement: High dose potato
- Dietary supplement: High dose French fries
- Dietary supplement: Basal diet control
Detailed Description
The study will compare uptake of potassium from three different doses and sources; supplements (720, 1440 and 2160 mg) potatoes (720, 1440 and 2160 mg) or French fries (2160 mg).
During 9 phases, participants will consume a controlled diet with the supplements, potato or french fries (every other week for 5 days). On the 4th day, blood and urine samples will be taken to monitor potassium uptake and excretion. Measures of blood pressure will be analyzed at defined time points throughout the intervention.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Indiana
-
West Lafayette, Indiana, United States, 47907
- Purdue University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Able to adhere to the visit schedule, protocol requirements and available to complete the study
- Normotensive men and women
- Aged 20-60 years
- BMI of 15-35
Exclusion Criteria:
- Medication to treat hypertension or hypotension
- Medication known to affect electrolyte metabolism or contain high levels of potassium or sodium
- smoke cigarettes or use illegal drugs
- Hypertension or hypotension
- Diseases known to affect potassium metabolism
- Pregnant
- Allergic to nuts
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Placebo Comparator: Placebo control
Subjects will consume tablets containing no potassium in addition to a basal diet containing 2336 mg potassium
|
|
Experimental: Low dose potassium gluconate
Subjects will consume 720 mg potassium in the form of potassium gluconate tablets daily in addition to a basal diet containing 2336 mg potassium
|
|
Experimental: Medium dose potassium gluconate
Subjects will consume 1440 mg potassium in the form of potassium gluconate tablets daily in addition to a basal diet containing 2336 mg potassium
|
|
Experimental: High dose potassium gluconate
Subjects will consume 2160 mg potassium in the form of potassium gluconate tablets daily in addition to a basal diet containing 2336 mg potassium
|
|
Experimental: Low dose potato
Subjects will consume 720 mg potassium in the form of potato daily in addition to a basal diet containing 2336 mg potassium
|
|
Experimental: Medium dose potato
Subjects will consume 1440 mg potassium in the form of potato daily in addition to a basal diet containing 2336 mg potassium
|
|
Experimental: High dose potato
Subjects will consume 2160 mg potassium in the form of potato daily in addition to a basal diet containing 2336 mg potassium
|
|
Experimental: High dose French fries
Subjects will consume 2160 mg potassium in the form of french fries daily in addition to a basal diet containing 2336 mg potassium
|
|
Experimental: Basal diet control
Subjects will consume a basal diet containing 2336 mg potassium daily
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Bioavailability of Potassium
Time Frame: 5 days
|
After 4 days of acclimation to the supplementation, absorption of potassium will be measured.
|
5 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Blood Pressure Response to Potassium
Time Frame: 6 days
|
Differences in blood pressure will be measured between levels of potassium consumption.
|
6 days
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Connie M Weaver, Ph.D., Purdue University
- Study Director: Berdine R Martin, Ph.D., Purdue University
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 1301013174
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Blood Pressure
-
SE HealthCentre for Aging and Brain Health InnovationCompletedHypertension | Blood Pressure | Hypotension | High Blood Pressure | Low Blood PressureCanada
-
DongGuk UniversityActive, not recruitingHypertension | Blood Pressure | Ambulatory Blood Pressure | Home Blood Pressure MeasurementKorea, Republic of
-
University of JordanCompletedBlood Pressure | Heart Rate | Airway PressureJordan
-
ROX Medical, Inc.CompletedHypertension | Blood Pressure, High | Blood Pressure, Resistant | Blood Pressure, UncontrolledUnited Kingdom, Netherlands, Belgium
-
Istituto Auxologico ItalianoRecruitingArterial Hypertension | Ambulatory Blood Pressure Monitoring | Blood Pressure Determination | Home Blood Pressure MonitoringItaly
-
RadiRad Co., Ltd.Hualien Tzu Chi General HospitalNot yet recruitingBlood Pressure
-
Riphah International UniversityRecruiting
-
GE HealthcareNot yet recruiting
-
Guangdong Provincial People's HospitalRecruiting
-
Guangdong Provincial People's HospitalRecruiting
Clinical Trials on Placebo control
-
Yooyoung Pharmaceutical Co., Ltd.RecruitingDyslipidemiasKorea, Republic of
-
Vanda PharmaceuticalsCompleted
-
SIMR (Australia) Biotech Pty Ltd.CompletedPeripheral Neuropathic PainAustralia
-
PfizerNot yet recruiting
-
Affiris AGCompletedAlzheimer's DiseaseFrance, Austria, Croatia, Germany, Czech Republic, Slovakia
-
Cellphire Therapeutics, Inc.Department of Health and Human ServicesCompleted
-
Nature Cell Co. Ltd.CompletedAlzheimer DiseaseUnited States
-
Promius Pharma, LLCTerminatedOnychomycosisUnited States
-
McMaster UniversityCompletedMuscle Protein SynthesisCanada
-
Probi ABCompletedIrritable Bowel SyndromeNetherlands